Altona, German Institute Co-developing Tests for Tropical Diseases | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Germany's Bernhard Nocht Institute for Tropical Medicine and ADT Altona Diagnostic Technologies recently announced a collaboration to develop and market tests for tropical diseases.

The public-private partnership is budgeted for €9.6 million ($12.6 million) over the next four years, with €4.6 million in funding provided by the government of the City of Hamburg in Germany. The money is from the European Fund of Regional Development, an instrument of the European Union.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.